Does previous standard percutaneous nephrolithotomy impair retrograde intrarenal surgery outcomes?


Journal

International braz j urol : official journal of the Brazilian Society of Urology
ISSN: 1677-6119
Titre abrégé: Int Braz J Urol
Pays: Brazil
ID NLM: 101158091

Informations de publication

Date de publication:
Historique:
received: 29 03 2021
accepted: 01 08 2021
entrez: 1 9 2021
pubmed: 2 9 2021
medline: 10 9 2021
Statut: ppublish

Résumé

The objective of this study is to evaluate the impact of a previous standard percutaneous nephrolithotomy (PCNL) on the outcomes of retrograde intrarenal surgery (RIRS). Outcomes of RIRS performed from January 2017 to January 2020 in adult patients with residual stone fragments ≤20mm after a standard PCNL (Post-PCNL) and symptomatic adult patients with kidney stones ≤20mm (Control) were prospectively studied. Stone-free rate (SFR) was evaluated on a postoperative day 90 non-contrast computed tomography. Surgical complications based on Clavien-Dindo classification during the 90 days of follow-up were recorded. Outcomes of 55 patients and 57 renal units of the post-PCNL group were compared to 92 patients and 115 renal units of the control group. SFR was lower in post-PCNL group than in control (28/57, 49.1% vs. 86/115, 74.8%, p < 0.001). Overall complications were more frequent in post-PCNL group (p=0.004). Infundibula strictures were identified and incised with laser in 15/57 (26.3%) renal units of the post-PCNL group. Thirteen renal units had infundibulum stricture at the site of previous percutaneous tract (13/15; 86.7%, p=0.004) and one renal unit had three infundibula strictures. Postoperative complications were not affected by the treatment of infundibula strictures (p=0.198). Previous standard PCNL significantly impairs the outcomes of RIRS. Infundibula strictures can be found in 26.3% of the patients with residual stone fragments after standard PCNL for large burden kidney stones. The main site of infundibulum stricture after standard PCNL is the infundibulum of the entry calyx.

Identifiants

pubmed: 34469672
doi: 10.1590/S1677-5538.IBJU.2021.0253
pii: IBJU20210253
pmc: PMC8486447
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1198-1206

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright® by the International Brazilian Journal of Urology.

Déclaration de conflit d'intérêts

None declared.

Références

J Endourol. 2011 Jun;25(6):927-31
pubmed: 21542774
Lasers Med Sci. 2017 Apr;32(3):649-654
pubmed: 28161725
Eur Urol. 2008 Dec;54(6):1393-403
pubmed: 18715696
Cent European J Urol. 2017;70(1):69-75
pubmed: 28461992
Eur Urol. 2009 May;55(5):1190-6
pubmed: 18571315
Urology. 2011 Aug;78(2):277-81
pubmed: 21333334
Investig Clin Urol. 2020 Mar;61(2):115-126
pubmed: 32158962
J Endourol. 2006 Aug;20(8):556-9
pubmed: 16903814
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Clinics (Sao Paulo). 2013 Jun;68(6):892-5
pubmed: 23778484
Nat Rev Urol. 2015 May;12(5):281-8
pubmed: 25868563
Int Braz J Urol. 2019 Sep-Oct;45(5):948-955
pubmed: 31268643
Asian J Urol. 2020 Apr;7(2):110-115
pubmed: 32257803
Eur Urol. 2016 Mar;69(3):475-82
pubmed: 26344917
BJU Int. 2020 Mar;125(3):449-456
pubmed: 31610080
Int Braz J Urol. 2019 Jan-Feb;45(1):10-22
pubmed: 30620157
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Eur Urol. 2017 Aug;72(2):220-235
pubmed: 28237786
J Endourol. 2012 Nov;26(11):1425-30
pubmed: 22698147
J Urol. 2002 Jan;167(1):35-8
pubmed: 11743270
J Urol. 2016 Oct;196(4):1161-9
pubmed: 27238615
Curr Opin Urol. 2019 Mar;29(2):118-123
pubmed: 30507619
Eur Urol. 2016 Mar;69(3):468-74
pubmed: 26318710
World J Urol. 2016 Jun;34(6):771-8
pubmed: 26497824
J Endourol. 2018 Jan;32(1):28-32
pubmed: 29037066
Urology. 2019 Oct;132:63-68
pubmed: 31310774
J Endourol. 2018 Dec;32(12):1108-1113
pubmed: 30398369
J Endourol. 2011 Mar;25(3):431-5
pubmed: 21401396
Urolithiasis. 2016 Nov;44(6):545-550
pubmed: 27023713
J Endourol. 2010 Jun;24(6):961-7
pubmed: 20491573

Auteurs

Alexandre Danilovic (A)

Departamento de Urologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo - FMUSP, São Paulo, SP, Brasil.

Fábio César Miranda Torricelli (FCM)

Departamento de Urologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo - FMUSP, São Paulo, SP, Brasil.

Giovanni Scala Marchini (GS)

Departamento de Urologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo - FMUSP, São Paulo, SP, Brasil.

Carlos Batagello (C)

Departamento de Urologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo - FMUSP, São Paulo, SP, Brasil.

Fabio Carvalho Vicentini (FC)

Departamento de Urologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo - FMUSP, São Paulo, SP, Brasil.

Olivier Traxer (O)

Sorbonne Université, GRC n 20 Lithiase Renale, AP-HP, Hôpital Tenon, F-75020 Paris, France, University, Paris, France.

Miguel Srougi (M)

Divisão de Urologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brasil.

William C Nahas (WC)

Divisão de Urologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brasil.

Eduardo Mazzucchi (E)

Departamento de Urologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo - FMUSP, São Paulo, SP, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH